UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052635
Receipt number R000060052
Scientific Title Influence of tea aroma on sleep and stress in asthmatic patients -cross-over study-
Date of disclosure of the study information 2023/11/01
Last modified on 2023/10/30 19:03:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Influence of tea aroma on sleep and stress in asthmatic patients -cross-over study-

Acronym

Influence of tea aroma on sleep and stress in asthmatic patients

Scientific Title

Influence of tea aroma on sleep and stress in asthmatic patients -cross-over study-

Scientific Title:Acronym

Influence of tea aroma on sleep and stress in asthmatic patients

Region

Japan


Condition

Condition

Asthma

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examining the Effect of Tea Fragrance on Sleep and Stress in asthma patient

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Epwards drowsiness scale
Athens Insomnia Scale
Pittsburgh Sleep Scale
microtag activity meter
SCL30
SF-36
SDS
salivary chromogranin

Key secondary outcomes

Asthma Control Test
Feno


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

During the first 2 weeks of Period I, the patients will be exposed to tea-scented water for 3 hours a day when they fall asleep using a diffuser. Placebo (water) will be diffused and volatilized when the patient falls asleep 3 hours a day for 2 weeks in Period II

Interventions/Control_2

During the first 2 weeks of Period I, placebo (water) will be diffused and volatilized when the subjects fall asleep 3 hours a day. During the second 2 weeks of Period II, the patients will be exposed to tea-scented water for 3 hours a day when they fall asleep using a diffuser.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1.Patients diagnosed with bronchial asthma
2.Patients who have given written consent for the study

Key exclusion criteria

1.Patients with tea allergy
2.Patients scheduled for hospitalization
3.Patients diagnosed with dementia
4.Patients currently participating in other clinical studies
5.Patients deemed inappropriate by the attending physician

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Miyuki
Middle name
Last name Otsubo

Organization

Saga University

Division name

Department of lifelong developmental nursing

Zip code

849-8501

Address

5-1-1 Nabeshima, Saga, Saga Prefecture

TEL

0952-34-2559

Email

tsubomi@cc.saga-u.ac.jp


Public contact

Name of contact person

1st name Miyuki
Middle name
Last name Otsubo

Organization

Department of Nursing, Saga University School of Medicine

Division name

Department of lifelong developmental nursing

Zip code

849-8501

Address

5-1-1 Nabeshima, Saga, Saga Prefecture

TEL

0952342559

Homepage URL


Email

tsubomi@cc.saga-u.ac.jp


Sponsor or person

Institute

Saga University

Institute

Department

Personal name



Funding Source

Organization

Saga University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saga University

Address

5-1-1 Nabeshima, Saga, Saga Prefecture

Tel

0952343357

Email

kenkyu-shinsei@ml.cc.saga-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

佐賀大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2023 Year 11 Month 01 Day


Related information

URL releasing protocol

not clear

Publication of results

Unpublished


Result

URL related to results and publications

http://jsa72.umin.jp/

Number of participants that the trial has enrolled

21

Results

There were 18 patients with good asthma control.Initial sleep evaluation showed that insomnia was suspected (6 points or higher) in 9 patients. 8 people had problems (scores of 6 or more).The microtag activity meter showed that those who volatilized black tea scented water had a total sleep time of 35 minutes longer, sleep effectiveness increased by 8.3%, the number of mid-day awakenings decreased by 2.4 times, and sleep latency. The time was reduced by 15.1 minutes.

Results date posted

2023 Year 10 Month 27 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The age of the 18 participants (1male, 17female)

Participant flow

Respiratory physicians were asked to recruit and 21 agreed to participate. They were randomized and divided into two groups. A total of 18 subjects were included: 9 in the placebo-first group (water to tea-scented water) and 9 in the aroma-first group (tea-scented water to water).

Adverse events

None noted

Outcome measures

Sleep was assessed using objective measurements with a microtag activity meter, the Athens Insomnia Scale, and the Pittsburgh Sleep Questionnaire.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 11 Month 01 Day

Date of IRB

2019 Year 12 Month 20 Day

Anticipated trial start date

2019 Year 12 Month 21 Day

Last follow-up date

2021 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 10 Month 27 Day

Last modified on

2023 Year 10 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060052